{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:14:58Z","timestamp":1783653298163,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","igiejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iGIE"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.igie.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:14:19Z","timestamp":1773335659000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence detection of endoscopic moderate-to-severe ulcerative colitis: a novel tool to enhance clinical trial recruitment"],"prefix":"10.1016","volume":"5","author":[{"given":"Laurie B.","family":"Grossberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Geeganage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Deyhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Santisteban-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papamichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler M.","family":"Berzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren G.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.igie.2026.03.001_bib1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.igie.2026.03.001_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/apt.18294","article-title":"Review article: novel therapies in inflammatory bowel disease\u2013an update for clinicians","volume":"60","author":"Noor","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.igie.2026.03.001_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ibd\/izz204","article-title":"Real-world effectiveness of advanced therapies among patients with moderate to severe ulcerative colitis in the United States","volume":"26","author":"Long","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.igie.2026.03.001_bib5","first-page":"347","article-title":"Predictors of hospital readmissions for ulcerative colitis in the United States: a national database study","volume":"23","author":"Poojary","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.igie.2026.03.001_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2021.03.065","article-title":"Challenges and opportunities in IBD clinical trial design","volume":"161","author":"Dubinsky","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ecco-jcc\/jjad020","article-title":"Declining enrolment and other challenges in IBD clinical trials: causes and potential solutions","volume":"17","author":"Uzzan","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.igie.2026.03.001_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2020.12.017","article-title":"Endoscopic assessment of inflammatory bowel disease activity in clinical trials","volume":"20","author":"Khanna","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.igie.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2020.10.065","article-title":"Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD","volume":"160","author":"Le Berre","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/gutjnl-2020-320690","article-title":"Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments","volume":"70","author":"Gottlieb","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.igie.2026.03.001_bib12","article-title":"Inflammatory bowel disease patients\u2019 perspectives of clinical trials: a global quantitative and qualitative analysis","volume":"3","author":"Rubin","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.igie.2026.03.001_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","article-title":"Artificial intelligence applied to clinical trials: opportunities and challenges","volume":"13","author":"Askin","year":"2023","journal-title":"Health Technol (Berl)"},{"key":"10.1016\/j.igie.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.21037\/jgo-21-175","article-title":"Deploying an artificial intelligence-based online search tool to increase patients\u2019 access to and understanding of solid tumor gastrointestinal clinical trials","volume":"12","author":"Jordan","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.igie.2026.03.001_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3963","article-title":"Performance of a deep learning model vs human reviewers in grading endoscopic disease severity of patients with ulcerative colitis","volume":"2","author":"Stidham","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.igie.2026.03.001_bib16","series-title":"Artificial intelligence to improve patient recruitment for Inflammatory Bowel Disease clinical trials: AutoIBD [white paper]. Virgo Surgical Video Solutions, Inc","author":"Singh","year":"2024"},{"key":"10.1016\/j.igie.2026.03.001_bib17","article-title":"Reversing the tide: improving the recruitment of patients with inflammatory bowel disease in clinical trials in the United States","volume":"2","author":"Deepak","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.igie.2026.03.001_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2013.03.025","article-title":"The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis","volume":"145","author":"Feagan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ecco-jcc\/jjad029","article-title":"Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials","volume":"17","author":"Ahmad","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.igie.2026.03.001_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2025.02.039","article-title":"Artificial intelligence\u2013enabled clinical trials in inflammatory bowel disease: automating and enhancing disease assessment and study management","volume":"169","author":"Stidham","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2026.03.001_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/17562848251321915","article-title":"Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review","volume":"18","author":"Sedano","year":"2025","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.igie.2026.03.001_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241272001","article-title":"Artificial intelligence and machine learning technologies in ulcerative colitis","volume":"17","author":"Kulkarni","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.igie.2026.03.001_bib23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.dld.2023.11.005","article-title":"Can artificial intelligence replace endoscopists when assessing mucosal healing in ulcerative colitis? A systematic review and diagnostic test accuracy meta-analysis","volume":"56","author":"Rimondi","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.igie.2026.03.001_bib24","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.3748\/wjg.v29.i48.6168","article-title":"Challenges involved in the application of artificial intelligence in gastroenterology: the race is on!","volume":"29","author":"Christou","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.igie.2026.03.001_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.gie.2020.05.040","article-title":"Regulatory considerations for artificial intelligence technologies in GI endoscopy","volume":"92","author":"Walradt","year":"2020","journal-title":"Gastrointest Endosc"}],"container-title":["iGIE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949708626000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949708626000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:31:22Z","timestamp":1783650682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949708626000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2949708626000658"],"URL":"https:\/\/doi.org\/10.1016\/j.igie.2026.03.001","relation":{},"ISSN":["2949-7086"],"issn-type":[{"value":"2949-7086","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence detection of endoscopic moderate-to-severe ulcerative colitis: a novel tool to enhance clinical trial recruitment","name":"articletitle","label":"Article Title"},{"value":"iGIE","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.igie.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Gastrointestinal Endoscopy.","name":"copyright","label":"Copyright"}]}}